Human chorionic gonadotropin (hCG) is no longer a single, omnipotent ovulation triggering option. Gonadotropin releasing hormone (GnRH) agonist, initially presented as a substitute for hCG, has led to a new era of administering GnRH agonist followed by hCG triggering. According to this new concept, GnRH agonist enables successful ovum maturation, while hCG supports the luteal phase and pregnancy until placental shift.
CITATION STYLE
Klement, A. H., & Shulman, A. (2017, May 17). hCG triggering in ART: An evolutionary concept. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms18051075
Mendeley helps you to discover research relevant for your work.